← Back to Search

Pharmacist Intervention to Reduce Post-Hospitalization Utilization

Waitlist Available
Led By Joshua Pevnick
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
10 or more prescription medications at admission
Screening 3 weeks
Treatment Varies
Follow Up hospitalization to the same hospital or ed visit within 30 days of discharge
Awards & highlights

Study Summary

This trial is testing a medication management intervention led by pharmacists on readmissions and emergency department visits within 30 days of discharge. The intervention focuses on evidence addressing three main areas: medication reconciliation, medication adherence, and polypharmacy.

Who is the study for?
This trial is for older adults (55+) who are at risk of medication issues after leaving the hospital. They must be taking more than 10 prescription meds or over three high-risk meds like blood thinners or diabetes drugs. It's not for those without stable housing, discharged out-of-state, in hospice care, previously enrolled, under certain specialists' care, or with COVID-19.Check my eligibility
What is being tested?
The study tests a pharmacist-led program to manage medications when patients leave the hospital. The goal is to see if this helps reduce emergency visits and readmissions within 30 days post-discharge. Patients are randomly chosen to either get this extra pharmacy help or usual care.See study design
What are the potential side effects?
Since this trial involves a service (medication management) rather than a drug, traditional side effects aren't expected. However, there may be unintended consequences related to changes in medication use as advised by pharmacists.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
This criterion does not apply to me.
I am taking 10 or more prescription medications.
I am currently admitted to a hospital ward.
I am 55 years old or older.
I am taking 3 or more high-risk medications like blood thinners or diabetes drugs.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~hospitalization to the same hospital or ed visit within 7 days of discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and hospitalization to the same hospital or ed visit within 7 days of discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate (%) of 30-day post-discharge hospitalization and ED visits (including hospitals at least statewide)
Secondary outcome measures
Perinatal death
Rate (%) of 30 day post-discharge hospitalizations and ED visits (same hospital) among patients who were enrolled and received the intervention, compared to patients who were eligible yet not enrolled during the study period.
Heart rate
+15 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Pharmacist ArmExperimental Treatment1 Intervention
Pharmacist-Led Medication Reconciliation, Regimen Review, and Adherence and Literacy Assessment and Counseling
Group II: Usual CareActive Control1 Intervention
Patients in this study will receive usual care. Clinically-indicated services, including pharmacist services, may be provided to control group patients.

Find a Location

Who is running the clinical trial?

Cedars-Sinai Medical CenterLead Sponsor
499 Previous Clinical Trials
158,379 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,669 Previous Clinical Trials
27,998,636 Total Patients Enrolled
Joshua PevnickPrincipal InvestigatorAssociate Professor of Medicine

Media Library

Pharmacist-led Hospital Discharge Care Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04071951 — N/A
Readmissions Research Study Groups: Usual Care, Pharmacist Arm
Readmissions Clinical Trial 2023: Pharmacist-led Hospital Discharge Care Intervention Highlights & Side Effects. Trial Name: NCT04071951 — N/A
Pharmacist-led Hospital Discharge Care Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04071951 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities for people to enroll in this medical experiment?

"The clinicaltrials.gov page for this trial indicates that it is no longer recruiting participants, with the initial post being dated December 23rd 2019 and the last update taking place on September 7th 2022. Fortunately, there are 24 other studies accepting new patients at present."

Answered by AI
~1234 spots leftby Apr 2025